Intrahepatic amino acid and glucose metabolism in a D-galactosamine-induced rat liver failure model

Hepatology

Volumn 34, Issue 2, 2001, Pages 360-371

  Arai, K ^a   Lee, K ^a   Berthiaume, F ^a   Tompkins, R G ^a   Yarmush, M L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; AMINO ACID; AMMONIA; BOVINE SERUM ALBUMIN; GALACTOSAMINE; GLUCOSE; GLUTAMIC ACID; TRICARBOXYLIC ACID;

AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLYCOLYSIS; ISOLATED LIVER; LIVER FAILURE; LIVER FUNCTION; LIVER METABOLISM; NONHUMAN; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; RAT; UREA CYCLE;

EID: 0034923583     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.26515     Document Type: Article

References (70)

1. Acute liver failure
2. Emergency liver transplantation for fulminant hepatitis
3. Emergency liver transplantation for fulminant liver failure in infants and children
4. Liver transplantation for fulminant hepatic failure
5. Brief report: Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation
6. The Hepatix extracorporeal liver assist device: Initial clinical experience
7. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase 1 clinical trial
8. Hepatic coma: Present concepts of pathogenesis and therapy
9. Synergism between mercaptans and ammonia or fatty acids in the production of coma: A possible role for mercaptans in the pathogenesis of hepatic coma
10. Ammonia-induced brain edema and intracranial hypertension in rats after portocaval anastomosis
11. Amino acids in liver failure
12. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: Characterization of an improved model and study of amino acid-ergic neurotransmission
13. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats
14. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy
15. Plasma amino acid patterns in hepatic encephalopathy of differing etiology
16. The effect of normalization of plasma amino acids on hepatic encephalopathy in man
17. Nutritional support in hepatic encephalopathy
18. Amino acid release by isolated perfused cirrhotic livers
19. Branched-chain amino acid metabolism in isolated perfused liver of cirrhotic rats
20. Characteristics of nitrogen metabolism in rats with thioacetamide-induced liver cirrhosis
21. Changes in hepatic nitrogen metabolism in isolated perfused liver during the development of thioacetamide-induced cirrhosis in rats
22. Metabolic studies in experimental liver disease resulting from D(+)-galactosamine administration
23. Metabolic flux analysis: A powerful tool for monitoring tissue function
24. Metabolic engineering: Techniques for the analysis of targets for genetic manipulations
25. Metabolic flux analysis of post-burn hepatic hypermetabolism
26. Experimental hepatitis induced by D-galactosamine
27. Ultrastructural features in galactosamine-induced hepatitis
28. Immunopathology of acute galactosamine hepatitis in rats
29. A model of fulminant hepatic failure in the rabbit
30. +-ATPase activity in rats with galactosamine-induced hepatic failure: Relationship to encephalopathy and cerebral oedema
31. Regional cerebral edema and chloride space in galactosamine-induced liver failure in rats
32. A fulminant hepatic failure model in the rat: Involvement of interleukin-1β and tumor necrosis factor α
33. Liver perfusion: An in vitro technique for the study of intracellular protein turnover and its regulation in vivo
34. Effect of burn injury on glucose and nitrogen metabolism in the liver: Preliminary studies in a perfused liver system
35. Effect of nonessential nitrogen supplements on growth and on amino acid content in plasma and muscle of weaning rats fed a low-protein diet
36. Effects of hypophysectomy on amino acid metabolism and gluconeogenesis in the perfused rat liver
37. Metabolic effects of stress mediators on cultured hepatocytes
38. Applications of amino acid derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate. Analysis of feed grains, intravenous solutions and glycoproteins
39. Stimulation of rat kidney phosphoenolpyruvate carboxykinase activity in experimental liver disease induced by galactosamine
40. Dissociation between renal gluconeogenesis and ammoniagenesis after acute liver intoxication
41. The role of plasma amino acids in hepatic encephalopathy
42. Plasma amino acid patterns in experimental acute hepatic failure: Comparison between hepatectomy and liver devascularization in pigs
43. Effect of alanine on D-galactosamine-induced acute liver failure in rats
44. L-Ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure
45. 4
46. Exaggeration of acute liver damage by hepatic sympathetic nerves and circulating catecholamines in perfused liver of rats treated with D-galactosamine
47. Systemic and hepatic hemodynamic changes in acute liver injury
48. Hepatic blood flow and splanchnic oxygen consumption in patients with liver failure. Effect of high-volume plasmapheresis
49. Contribution of the arterial blood ketone body ratio to elevate plasma amino acids in hepatic encephalopathy of surgical patients
50. Splanchnic and leg exchange of amino acids and ammonia in acute liver failure
51. The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia
52. Immunopathology of acute galactosamine hepatitis in rats
53. Regulation of flux through glutaminase and glutamine synthetase in isolated perfused rat liver
54. Zonation of acetaminophen metabolism and cytochrome P450 2E1-mediated toxicity studied in isolated periportal and perivenous hepatocytes
55. Dysregulation of protein synthesis in injured liver. A comparative study on microsomal and cytosole enzyme activities, microsomal lipoperoxidation and polysomal pattern in D-galactosamine and carbon tetrachloride-injured livers
56. Influence of ammonium ions on hepatic de novo pyrimidine biosynthesis
57. Hepatic carbamoyl phosphate metabolism. Role of cytosolic and mitochondrial carbamoyl phosphate in de novo pyrimidine synthesis
58. Orotic acid, arginine, and hepatotoxicity
59. Control of pyrimidine biosynthesis in the perfused liver. Feedback inhibition of glutamine-dependent carbamoyl phosphate synthetase
60. Effects of putrescine on D-galactosamine-induced acute liver failure in rats
61. Effect of alanine on polyamine metabolism in hepatocytes with cellular injury induced by D-galactosamine
62. Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels
63. Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design
64. Glucoregulation in acute liver failure
65. Studies on gluconeogenesis in galactosamine induced hepatitis
66. Application of macroscopic balances to the identification of gross measurement errors
67. Application of metabolic pathway stoichiometry to statistical analysis of bioreactor measurement data